Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation

Cell Death and Differentiation

Volumn 5, Issue 9, 1998, Pages 765-773

  Aziz Aloya, Revital Ben ^a   Levanon, Ditsa ^a   Karn, Heather ^a   Kidron, Debora ^b   Goldenberg, Dalia ^a   Lotem, Joseph ^a   Polak Chaklon, Sylvie ^c   Groner, Yoram ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c Tel Hashomer Hospital   (Israel)

Author keywords

Altered in vivo differentiation; AML1 short isoform; Enhanced apoptosis; ES cells induced teratocarcinomas

Indexed keywords

GENE PRODUCT; MESSENGER RNA; PROTEIN; TRANSCRIPTION FACTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GENETICS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO CELL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH REGULATION; HEMATOPOIESIS; HISTOLOGY; MALE; MOUSE; NONHUMAN; ONCOGENE; PLEIOTROPY; PRIORITY JOURNAL; STEM CELL; TERATOCARCINOMA; TRANSACTIVATION; TUMOR GROWTH;

EID: 7344248552     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400415     Document Type: Article

References (51)

1. Adra CN, Boer PH and McBumey MV (1987) Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter Gene 60: 65-74
2. Bae S-C, Ogawa E, Maruyama M, Oka H, Satake M, Shigesada K, Jenkins NA, Gilbert DJ, Copeland NG and Ito Y (1994) PEBP2aB/Mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol. Cell Biol. 14: 3242-3252
3. Bae S-C, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M and Ito Y (1993) Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1 Oncogene 8: 809-814
4. Bruhn L, Munnerlyn A and Grosschedl R (1997) ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRa enhancer function Genes & Develop. 11: 640-653
5. Doetschman TC, Eistetter H, Katz M, Schmidt M and Kemler R (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol. Exp Morph 87: 27-45
6. Eustice DC, Feldman PA, Colberg-Poley AM, M BR and Neubauer RH (1991) A sensitive method for the detection of b-galactosidase in transfected mammalian cells. BioTechniques 11: 739-742
7. Evans MJ and Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nautre 292: 154-156
8. Frank R, Zhang J, Uchida H, Meyers S, Hiebert SW and S Nimer D (1995) The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 11: 2667-2674
9. Furukawa K, Yamaguchi Y, Ogawa E, Shigesada K, Satake M and Ito Y (1990) A ubiquitous represser interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors Cell Growth Differ 1: 135-147
10. Gavrieli Y, Sherman Y and Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
11. Ghozi MC, Bernstein Y, Negreanu V, Levanon D and Groner Y (1996) Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions Proc. Natl. Acad. Sci. USA 93: 1935-1940
12. Giese K, Kingsley C, Kirshner JR and Grosschedl R (1995) Assembly and function of a TCRa enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes & Develop. 9: 995-1008
13. Haviv I, Vaizel D and Shaul Y (1995) The X protein of hepatitis B virus coactivates potent activation domains Mol. Cell. Biol 15. 1079-1085
14. Hilberg F and Wagner EF (1992) Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity Oncogene 7: 2371-2380
15. Ito Y (1996) Structural alterations in the transcription factor PEBP2/CBF linked to four different types of leukemia. J. Cancer Res Clin. Oncol. 122: 266-274
16. Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi H, Ohki M, Pepling M and Gergen P (1993) The runt domain identifies a new family of heteromeric DNA-binding transcriptional regulatory proteins. Trend. Genet. 9: 338-341
17. Keller G, Kennedy M, Papayannopoulou T and Wiles MV (1993) Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13: 473-486
18. Keller GM (1995) In vitro differentiation of embryonic stem cells Curr. Opin. Cell Biol. 7: 862-869
19. Krimpenfort P, Jong RD, Uematsu Y, Dembic Z, Ryser S, Boehmer HV, Steinmetz M and Berns A (1988) Transcription of T cell receptor beta-chain genes is controlled by a downstream regulatory element. EMBO J. 7: 745-750
20. Kurokawa M, Tanaka T, Tanaka K, Ogawa S, Mitani K, Yazaki Y and Hirai H (1996) Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on DNA-binding and transactivational potencies. Oncogene 12: 883-892
21. Levanon D, Bernstein Y, Negreanu V, Ghozi MC, Bar-Am I, Aloya R, Goldenberg D, Lotem J and Groner Y (1996) A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA and Cell Biol. 15. 175-185
22. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L and Groner Y (1994) AML1, AML2, and AML3, the human members of the runt domain gene-family, cDNA structure, expression and chromosomal localization. Genomics 23: 425-432
23. Meyers S and Hiebert SW (1995) Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. Crit. Rev. Eukaryot Gene Exp. 5: 365-383
24. Meyers S, Lenny N and Hiebert SW (1995a) The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell. Biol. 15: 1974-1982
25. Meyers S, Lenny N, Sun W-H and Hiebert SW (1995b) AML-2 is a potential target for the t(8;21) fusion protein in myeloid cells. Blood 86: 38a
26. Miyoshi H, Ohira M, Shimizu K, Mitani K, Hirai H, Imai T, Yokoyama K, Soeda E and Ohki M (1995) Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia Nucl. Acid Res. 23: 2762-2769
27. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y and Ohki M (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad. Sci. USA 88: 10431-10434
28. Niitsu N, Yamamoto-Yamaguchi Y, Miyoshi H, Shimizu K, Ohki M, Umeda M and Honma Y (1997) AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells. Cell Growth & Diff. 8. 319-326
29. Nisson PE, Watkins PC and Sacchi N (1992) Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells Cancer Genet. Cytogenet. 63: 81-88
30. Nucifora G, Begy CR, Erickson P, Drabkin HA and Rowley JD (1993a) The 3:21 translocation in myelodysplasia results in a fusion transcript betwen the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER1. Proc. Natl Acad. Sci. USA 90: 7784-7788
31. Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, Parganas E, Ihle JN and Rowley JD (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 and 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc. Natl Acad Sci. USA 91. 4004-4008
32. Nucifora G, Birn DJ, Espinosa III R, Erickson P, Le Beau MM, Roulston D, McKeithan TW, Drabkin H and Rowley JD (1993b) Involvement of the AML1 gene in the t(3,21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 81: 2728-2734
33. Nucifora G and Rowley JD (1995) AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86: 1-14
34. Okuda T, Deursen JV, Hiebert SW, Grosveld G and Downing JR (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321-330
35. Pongubala JR and Atchison ML (1997) PU.1 can participate in an active enhancer complex without its transcriptional activation domain Proc. Natl. Acad. Sci. USA 94 127-132
36. QIU F. Ray P, Brown K, Barker PE, Jhanwar S, Ruddle FH and Besmer P (1988) Primary structure of c-kit relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J. 7: 1003-1011
37. Rothwell VM and RohrschneiderLR4 (1987) Myrine c-fms cDNA: cloning, sequence analysis and retroviral expression, Oncogene Res. 1:311-324
38. Sacchi N, Nisson PE, Watkins PC, Faustinella F, Wijsman J and Hagemeijer A (1994) AML1 fusion transcripts in t(3;21) positive leukemia Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts. Genes, Chrom. Cancer 11:226-236
39. Satake M, Nomura S, Yamaguchi-Iwai Y, Takahama Y, Hashimoto Y, Niki M, Kitamura Y and Ito Y (1995) Expression of the runt domain-encoding PEBP2a genes in T cells during thymic development. Mol. Cell Biol. 15: 1662-1670
40. Smith AG (1991) Culture and differentiation of embryonic stem cells. J. Tiss. Cult Meth. 13 89-94
41. Speck NA and Stacy T (1995) A new transcription factor family associated with human leukemias. Crit. Rev. Eukaryot. Gene Exp. 5: 337-364
42. Talerman A (1994) Germ cell tumors of the ovary. In RJ Kurman, ed Blaustein's pathology of the female genital tract. (New York: Springer-Verlag press), pp. 850-896
43. Tanaka K, Tanaka T, Ogawa S, Kurokowa M, Mitani K, Yazaki Y and Hirai H (1995) Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells. Biochem. Biophys. Res Com 211: 1023-1030
44. TanakaT. Tanaka K, Ogawa S, Korokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y and Hirai H (1995a) An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistrically by two alternative spliced forms. EMBO J 14: 341-350
45. Wang Q, Stacy T, Binder M, Mari'n-Padilla M, Sharpe AH and Speck NA (1996) Disruption of the cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad, Sci. USA 93: 3444-3449
46. Wulf GM, Adra CN and Lim B (1993) Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA EMBO J. 12: 5065-5074
47. Yamada T, Kondoh N, Matsumoto M, Yoshida M, Maekawa A and Oikawa T (1997) Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Blood 89: 1383-1393
48. Yergeau DA, Hethenrigton CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Martin-Padilla M, Tenen DG, Speck NA and D-E Z (1997) Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nature Genetics 15. 303-306
49. Zent CS, Mathieu C, Claxton DF, Zhang D-E, Tenen DG, Rowley JD and Nucifora G (1996) The cimeric genes AML1/MDS1 and AML1/EAP inhibit AML1 activatin at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties Proc. Natl. Acad Sci. USA 93: 1044-1048
50. Zhang D-E, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen H-M, Hiebert SW and Tenen DG (1996) CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16: 1231-1240
51. Zhang Y-W, Bae S-C, Huang G, Fu Y-X, Lu J, Ahn M-Y, Kanno Y, Kanno T and Ito Y (1997) A novel transcript encoding an N-terminally truncated AML1/PEBP2αB protein interferes with transactivation and blocks granulocytic differentiation of 32Dc13 myeloid cells. Mol. Cell. Biol 17: 4133-4145